Demand for GLP-1 Drugs Creates New Fraud Risks

Demand for GLP-1 Drugs Creates New Fraud Risks

The explosive popularity of GLP-1 medications has created new challenges for insurers, health plans and fraud investigators, according to Stephanie Benson, CFE, senior manager in Evernorth Health Services’ Special Investigations Unit. During her virtual session at the 37th Annual ACFE Global Fraud Conference, she explored how social media-driven demand for weight loss drugs has contributed to emerging fraud schemes, misuse patterns and investigative concerns across the healthcare industry. 

Read More

29th Annual ACFE Global Fraud Conference Sessions Announced

29th Annual ACFE Global Fraud Conference Sessions Announced

More than 3,000 anti-fraud professionals will gather in Las Vegas, Nevada, June 17-22, 2018, for the 29th Annual ACFE Global Fraud Conference to power up their network, boost their skills and recharge their careers. You can now customize your schedules by choosing from more than 100 educational sessions across 13 tracks. The wide range of topics touches on nearly every facet of occupational fraud — from contract fraud to cross-border investigations to the Paradise Papers — with sessions for all levels of experience. Here are a few highlights:

Read More